Stay updated on Amivantamab Combo Therapy Clinical Trial
Sign up to get notified when there's something new on the Amivantamab Combo Therapy Clinical Trial page.
Latest updates to the Amivantamab Combo Therapy Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe study location list was updated to 232 sites with new entries including Zhejiang University’s Second Affiliated Hospital (Hangzhou), Hunan Cancer Hospital, Beijing Cancer Hospital, and The Royal Marsden locations; references to 229 sites were removed.SummaryDifference0.3%
- Check17 days agoNo Change Detected
- Check32 days agoChange DetectedStudy locations were updated: City of Hope was removed and City of Hope 2 was added. This affects where participants can enroll and which sites are available for the study.SummaryDifference0.1%
- Check39 days agoChange DetectedA new PAPILLON Asia subgroup analysis article (Lung Cancer, 2026) was added to Publications, and the online-ahead-of-print listing for that article was removed; the bibliographic entry was updated.SummaryDifference0.0%
- Check46 days agoChange DetectedUpdated the page revision from v3.4.2 to v3.4.3.SummaryDifference0.0%
- Check53 days agoChange DetectedThere are additions of four update dates: 2026-02-25, 2027-08-02, 2026-02-12, and 2026-02. It also shows deletions of four dates: 2026-02-04, 2026-09-30, 2026-01-15, and 2026-01.SummaryDifference0.1%
- Check68 days agoChange DetectedAdded a new publication reference: PAPILLON Asia subgroup analysis in Lung Cancer (2026) with DOI 10.1016/j.lungcan.2026.109302.SummaryDifference0.0%
Stay in the know with updates to Amivantamab Combo Therapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Amivantamab Combo Therapy Clinical Trial page.